A quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome.
Ontology highlight
ABSTRACT: Mass spectrometry (MS) -- based proteomic approaches have evolved as powerful tools for the discovery of biomarkers. However, the identification of potential protein biomarkers from biofluid samples is challenging because of the limited dynamic range of detection. Currently there is a lack of sensitive and reliable premortem diagnostic test for prion diseases. Here, we describe the use of a combined MS-based approach for biomarker discovery in prion diseases from mouse plasma samples. To overcome the limited dynamic range of detection and sample complexity of plasma samples, we used lectin affinity chromatography and multidimensional separations to enrich and isolate glycoproteins at low abundance. Relative quantitation of a panel of proteins was obtained by a combination of isotopic label
SUBMITTER: Wei X
PROVIDER: S-EPMC3107867 | biostudies-literature | 2011 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA